Medtronic Quarterly Cash Flow Statement
NYSE: MDTHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Medtronic free cash flow
In the quarter ended Jul 31, 2026, Medtronic generated $1.79 billion of operating cash flow and spent $503.0 million on capital expenditures. That left free cash flow of $1.29 billion, a free-cash-flow margin of 13.2% of revenue. Free cash flow was up 120.9% from the prior year's $584.0 million.
Medtronic returned $1.19 billion to shareholders: $921.0 million in dividends and $267.0 million in share repurchases, equal to 92% of free cash flow. Free cash flow covered dividend payments 1.4 times.
Summary generated from market data by MetaCap's automated system. Methodology
Medtronic cash flow statement (quarterly)
| Quarter (USD) | Q1 20272026-07-31 | Q4 20262026-04-24 | Q3 20262026-01-23 | Q2 20262025-10-24 | Q1 20262025-07-25 | Q4 20252025-04-25 | Q3 20252025-01-24 | Q2 20252024-10-25 | Q1 20252024-07-26 | Q4 20242024-04-26 | Q3 20242024-01-26 | Q2 20242023-10-27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.48B | 1.26B | 1.15B | 1.38B | 1.05B | 1.06B | 1.30B | 1.28B | 1.05B | 660.00M | 1.34B | 911.00M |
| Net Income growth (YoY) | +41.26% | +18.66% | -11.74% | +8.06% | -0.19% | +60.76% | -2.54% | +40.29% | +31.62% | -44.49% | +8.79% | +109.43% |
| Depreciation & Amortization | 729.00M | 716.00M | 749.00M | 745.00M | 748.00M | 840.00M | 684.00M | 675.00M | 662.00M | 654.00M | 649.00M | 672.00M |
| Stock-Based Compensation | 125.00M | 95.00M | 94.00M | 182.00M | 86.00M | 89.00M | 98.00M | 159.00M | 83.00M | 90.00M | 84.00M | 146.00M |
| Change in Working Capital | -771.00M | 522.00M | 572.00M | -481.00M | -971.00M | 552.00M | 350.00M | -164.00M | -821.00M | 1.03B | 532.00M | -232.00M |
| Operating Cash Flow | 1.79B | 2.57B | 2.74B | 925.00M | 1.09B | 2.53B | 2.57B | 958.00M | 986.00M | 2.78B | 2.47B | 661.00M |
| Capital Expenditures | -503.00M | -488.00M | -444.00M | -468.00M | -504.00M | -459.00M | -476.00M | -404.00M | -520.00M | -426.00M | -346.00M | -461.00M |
| Investing Cash Flow | -1.62B | -917.00M | -816.00M | -482.00M | -719.00M | -490.00M | -843.00M | -345.00M | -259.00M | -696.00M | -707.00M | -424.00M |
| Dividends Paid | -921.00M | -908.00M | -911.00M | -910.00M | -910.00M | -897.00M | -897.00M | -897.00M | -898.00M | -913.00M | -917.00M | -918.00M |
| Share Repurchases | -267.00M | -435.00M | -105.00M | -372.00M | -123.00M | -274.00M | -181.00M | -288.00M | -2.49B | -1.63B | -132.00M | -226.00M |
| Debt Issued | — | 0 | 0 | 1.75B | 0 | 0 | 0 | 0 | 3.21B | 0 | 0 | 0 |
| Debt Repaid | 0 | 0 | 0 | -1.77B | -1.16B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | -343.00M | -888.00M | -2.09B | -395.00M | -1.38B | -1.34B | -1.75B | -534.00M | -731.00M | -2.36B | -1.50B | -90.00M |
| Net Change in Cash | -258.00M | 803.00M | -136.00M | 9.00M | -945.00M | 978.00M | -154.00M | 83.00M | 27.00M | -339.00M | 312.00M | -28.00M |
| Free Cash Flow | 1.29B | 2.08B | 2.30B | 457.00M | 584.00M | 2.07B | 2.10B | 554.00M | 466.00M | 2.35B | 2.13B | 200.00M |
This table shows 12 quarterly periods of Medtronic's cash flow statement, from Q1 2027 back to Q2 2024, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MDT's reporting calendar. What is a cash flow statement?